Tuberculosis in the United Kingdom and Republic of Ireland
- S S S Teo1,
- A Riordan2,
- M Alfaham3,
- J Clark4,
- M R Evans5,
- M Sharland6,
- V Novelli7,
- J M Watson8,
- P Sonnenberg9,
- A Hayward9,
- J Moore-Gillon10,
- D Shingadia7,
- for the British Paediatric Surveillance Unit Childhood Tuberculosis Study Group
- 1University of London, London, UK
- 2Royal Liverpool Children’s Hospital, Liverpool, UK
- 3Llandough Hospital, Cardiff, UK
- 4Newcastle General Hospital, Newcastle, UK
- 5Communicable Disease Surveillance Centre, National Public Health Service for Wales, Cardiff, UK
- 6St George’s Hospital, London, UK
- 7Great Ormond Street Hospital, London, UK
- 8Health Protection Agency, Centre for Infections, London, UK
- 9University College London, London, UK
- 10St Bartholomew’s Hospital and Royal London Hospital, London, UK
- Dr Delane Shingadia, Department of Infectious Diseases, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK; shingd{at}gosh.nhs.uk
- Accepted 19 November 2008
- Published Online First 3 December 2008
Abstract
Aims: To describe the clinical features, diagnosis and management of children with tuberculosis in the United Kingdom and Republic of Ireland.
Methods: Cases of culture-confirmed and clinically diagnosed tuberculosis were reported to the British Paediatric Surveillance Unit from December 2003 to January 2005.
Results: 385 eligible cases were reported. Pulmonary disease was present in 154 (40%) children. Just over half (197, 51%) of children presented clinically and most of the remainder (166, 43%) at contact tracing. A probable source case was identified for 73/197 (36%) of the children presenting clinically. The majority (253, 66%) of children had a microbiological and/or histological investigation, and culture results were available for 240 (62%), of whom 102 (26%) were culture positive. Drug resistance was reported in 15 (0.4%) cases. 44% (128/292) of non-white children did not receive the recommended quadruple drug therapy. Seven children died. Only 57% (217) of children were managed by a paediatric subspecialist in respiratory or infectious diseases or a general paediatrician with a special interest in one of these areas. Fewer than five cases were reported from 119/143 (83%) respondents and 72 of 96 (75%) centres.
Conclusions: Many paediatricians and centres see few children with tuberculosis. This may affect adherence to national guidelines. Managed clinical networks for children with tuberculosis may improve management and should be the standard of care.
Footnotes
-
Funding: SSST was partially funded by a UK Department of Health research grant. The funding source had no involvement in study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
-
Competing interests: None.
-
Ethics approval: The study was approved by the South West Multi-Centre Research Ethics Committee.








